Polymerase Chain Reaction (PCR) Global Market - Forecast To 2025

Publishing Date : November, 2019
Report Code : HCBT 0099
Price:
Single license $4,950
Site license $6,750
Global license $9,000


 

Polymerase Chain Reaction (PCR) is a novel technique which amplifies the amount of target nucleic acid in every cycle. PCR has three steps such as denaturation, annealing and extension, which are repeated in every cycle to achieve the product. The PCR market is expected to reach $12,910.1 million by 2025 growing at a high single digit CAGR from 2019 to 2025. PCR market is segmented based on techniques, products, applications, end users and geography.

The factors driving the growth of PCR market are increasing demand for early detection of chronic diseases, increasing demand for genetic and molecular testing, high prevalence of infectious diseases, expiry of PCR patents of major players, increased investments in the field of companion diagnostics using PCR, increasing qPCR based food safety testing, technological advancements and growing demand for rapid diagnostic tests. However, factors like high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and stringent regulatory framework are hampering the market.

By Technique, the PCR market is segmented into standard PCR, real time PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, Hot start PCR and others. Others include nested PCR, Inverse PCR, Immune PCR, anchored PCR, RACE PCR, asymmetric PCR, universal PCR, ISSR PCR, allele specific PCR, ligation mediated PCR, touchdown PCR, solid phase PCR, methylation PCR, miniprimer PCR, nanoparticle assisted PCR, overlap extension PCR and In-situ PCR and long PCR. Among PCR Techniques, RealTime/qPCR segment accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025. The digital PCR segment is the fastest growing market in 2019 and is expected grow at a low double digit CAGR from 2019 to 2025.

The PCR global market by product is segmented into instruments, reagents and consumables and software and services, among the products Reagents and consumables accounted for largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025. The instruments segment is classified as traditional PCR’s and Real time PCR’s. Reagents and consumables are sub segmented into enzymes, dNTPs, template DNA, primers and probes, buffers, master mixes, nuclease free water, consumable and others (tracking dye and wax beads). Software’s in the PCR market include Primer designers and sequence software’s, PCR data analysis software and others.

By application, the market is segmented into clinical diagnostics, industrial application, and others. Clinical diagnostics segment is further divided into infectious and non infectious diseases. Infectious disease includes hepatitis B & C, tuberculosis, HIV and others. Non infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, biomedical research and other PCR industry applications. Applied testing includes forensic and food safety testing. Biomedical research includes DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA cloning and others. In PCR applications market, the industry segment accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025 and the clinical diagnosis segment is the fastest growing market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025.

By end- users, Academics accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025 and The Hospitals & laboratories segment is the fastest growing market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025. Geographically, North America accounted for largest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2025 and The APAC region is the fastest growing market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025.

Some of the major players in the PCR market are ThermoFisher Scientific, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Becton, Dickinson and Company (U.S.), BioMerieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Hoffmann la Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and Takara Bio, Inc.(Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific 
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others

TABLE OF CONTENTS

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     REQUIREMENT OF EARLY DETECTION OF DISEASE
        • 3.3.1.2     INCREASING DEMAND FOR PCR IN GENETIC AND MOLECULAR TESTING
        • 3.3.1.3     HIGH PREVALENCE OF INFECTIOUS DISEASES
        • 3.3.1.4     INCREASING QPCR BASED FOOD SAFETY TESTING
        • 3.3.1.5     EXPIRY OF KEY PLAYERS PCR PATENTS
        • 3.3.1.6     GROWING DEMAND FOR RAPID DIAGNOSTIC TESTS
        • 3.3.1.7     INCREASING USE OF COMPANION DIAGNOSTICS
        • 3.3.1.8     TECHNOLOGICAL ADVANCES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF COMMERCIAL PCR ASSAYS IN CLINICAL DIAGNOSTICS
        • 3.3.2.2     LACK OF AWARENESS AND REQUIREMENT OF SKILLED LABOR
        • 3.3.2.3     DEVELOPMENT OF ALTERNATE TECHNOLOGIES
        • 3.3.2.4     STRINGENT REGULATORY FRAMEWORK
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     INDIA
      • 3.4.7     JAPAN
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     COMPETITIVE RIVALRY
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.7.1     PCR GLOBAL MARKET SHARE ANALYSIS
    • 3.8     PATENT TRENDS
    • 3.9     REFURBISHED DEVICES
    • 3.10     FUNDING SCENARIO
  • 4     PCR GLOBAL MARKET, BY TECHNIQUES
    • 4.1     INTRODUCTION
    • 4.2     STANDARD PCR
    • 4.3     REAL TIME PCR/QPCR
    • 4.4     REVERSE TRANSCRIPTASE PCR
    • 4.5     DIGITAL PCR
    • 4.6     ASSEMBLY PCR
    • 4.7     MULTIPLEX PCR
    • 4.8     HOT START PCR
    • 4.9     OTHER PCR TECHNIQUES
  • 5     PCR GLOBAL MARKET, BY PRODUCT
    • 5.1     INTRODUCTION
    • 5.2     INSTRUMENTS
      • 5.2.1     TRADITIONAL THERMOCYCLER
      • 5.2.2     REAL TIME THERMOCYCLER
    • 5.3     REAGENTS AND CONSUMABLES
      • 5.3.1     ENZYMES
      • 5.3.2     DEOXYNUCLEOTIDE TRIPHOSPHATE'S (DNTP'S)
      • 5.3.3     TEMPLATES OR CONTROLS
      • 5.3.4     PRIMERS AND PROBES
      • 5.3.5     BUFFERS
      • 5.3.6     REAGENT KITS OR MASTER MIXES
      • 5.3.7     NUCLEASE FREE WATER
      • 5.3.8     CONSUMABLES
      • 5.3.9     OTHER REAGENTS AND CONSUMABLES
    • 5.4     SOFTWARE & SERVICES
  • 6     PCR GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     CLINICAL DIAGNOSTICS
      • 6.2.1     INFECTIOUS DISEASES
        • 6.2.1.1     HEPATITIS B AND C TESTING
        • 6.2.1.2     TUBERCULOSIS DIAGNOSIS
        • 6.2.1.3     HIV DIAGNOSIS
        • 6.2.1.4     OTHER INFECTIOUS DISEASE
      • 6.2.2     NON-INFECTIOUS DISEASES
        • 6.2.2.1     PRENATAL DIAGNOSIS
        • 6.2.2.2     TISSUE TYPING/TRANSPLANT
        • 6.2.2.3     CANCER THERAPY
        • 6.2.2.4     GENETIC TESTING FOR HEREDITARY DISEASES
        • 6.2.2.5     BLOOD SCREENING
        • 6.2.2.6     OTHER NON-INFECTIOUS APPLICATIONS
    • 6.3     INDUSTRIAL APPLICATIONS
      • 6.3.1     AGRICULTURE
      • 6.3.2     ENVIRONMENT
      • 6.3.3     APPLIED TESTING
        • 6.3.3.1     FORENSICS
        • 6.3.3.2     FOOD SAFETY TESTING
      • 6.3.4     ANIMAL HUSBANDRY
      • 6.3.5     BIOMEDICAL RESEARCH
        • 6.3.5.1     DNA SEQUENCING
        • 6.3.5.2     GENOTYPING
        • 6.3.5.3     BIOMARKER DISCOVERY
        • 6.3.5.4     GENE EXPRESSION AND GENETIC MAPPING
        • 6.3.5.5     DNA CLONING
        • 6.3.5.6     OTHER BIOMEDICAL RESEARCH APPLICATIONS
      • 6.3.6     OTHER PCR INDUSTRY APPLICATIONS
    • 6.4     OTHER PCR APPLICATIONS
  • 7     PCR GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS AND LABORATORIES
    • 7.3     PHARMACEUTICALS, CRO'S AND BIOTECH
    • 7.4     ACADEMICS
    • 7.5     OTHER PCR END USERS
  • 8     REGIONAL ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     U.K.
      • 8.3.3     FRANCE
      • 8.3.4     REST OF EUROPE
    • 8.4     APAC
      • 8.4.1     CHINA
      • 8.4.2     JAPAN
      • 8.4.3     INDIA
      • 8.4.4     REST OF APAC
    • 8.5     ROW
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATAM
      • 8.5.3     MIDDLE EAST & OTHERS
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     APPROVALS
    • 9.3     NEW PRODUCT LAUNCH
    • 9.4     ACQUISITION, AGREEMENTS AND PARTNERSHIP
    • 9.5     OTHERS
  • 10     MAJOR COMPANIES
    • 10.1     ABBOTT LABORATORIES, INC.
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     AGILENT TECHNOLOGIES
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BECTON DICKINSON AND COMPANY
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     BIOMERIEUX SA
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENSTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     BIO-RAD LABORATORIES
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     F.HOFFMANN-LA ROCHE LTD (ROCHE DIAGNOSTICS)
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     MERCK KGAA
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     PROMEGA CORPORATION
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     QIAGEN N.V.
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
    • 10.11     TAKARA BIO, INC.
      • 10.11.1     OVERVIEW
      • 10.11.2     FINANCIALS
      • 10.11.3     PRODUCT PORTFOLIO
      • 10.11.4     KEY DEVELOPMENTS
      • 10.11.5     BUSINESS STRATEGY
      • 10.11.6     SWOT ANALYSIS
    • 10.12     THERMO FISHER SCIENTIFIC, INC.
      • 10.12.1     OVERVIEW
      • 10.12.2     FINANCIALS
      • 10.12.3     PRODUCT PORTFOLIO
      • 10.12.4     KEY DEVELOPMENTS
      • 10.12.5     BUSINESS STRATEGY
      • 10.12.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 2     PCR GLOBAL MARKET REVENUE, BY TECHNIQUES, (2018-2025) ($MN)
      • TABLE 3     STANDARD PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 4     REAL TIME PCR/QPCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 5     REVERSE TRANSCRIPTASE PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 6     DIGITAL PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 7     ASSEMBLY PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 8     MULTIPLEX PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 9     HOT START PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 10     OTHER PCR TECHNIQUES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 11     PCR GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 12     INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 13     INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 14     TRADITIONAL THERMOCYCLER GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 15     REAL TIME THERMOCYCLER GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 16     REAGENTS & CONSUMABLES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 17     REAGENTS AND CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 18     ENZYMES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 19     DNTP'S GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 20     TEMPLATES OR CONTROLS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 21     PRIMERS AND PROBES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 22     BUFFERS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 23     REAGENT KITS OR MASTER MIXES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 24     NUCLEASE FREE WATER GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 25     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 26     OTHER REAGENTS AND CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 27     SOFTWARE & SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 28     PCR GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2025) ($MN)
      • TABLE 29     CLINICAL DIAGNOSTICS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2018-2025) ($MN)
      • TABLE 30     CLINICAL DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 31     INFECTIOUS DISEASES GLOBAL MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 32     INFECTIOUS DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 33     HEPATITIS B AND C TESTING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 34     TUBERCULOSIS DIAGNOSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 35     HIV DIAGNOSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 36     OTHER INFECTIOUS DISEASE GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 37     NON-INFECTIOUS DISEASES GLOBAL MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 38     NON-INFECTIOUS DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 39     PRENATAL DIAGNOSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 40     TISSUE TYPING/TRANSPLANT GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 41     CANCER THERAPY GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 42     GENETIC TESTING FOR HEREDITARY DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 43     BLOOD SCREENING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 44     OTHER NON-INFECTIOUS APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 45     INDUSTRIAL APPLICATIONS GLOBAL MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 46     INDUSTRIAL APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 47     AGRICULTURE GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 48     ENVIRONMENT GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 49     APPLIED TESTING GLOBAL MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 50     APPLIED TESTING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 51     FORENSICS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 52     FOOD SAFETY TESTING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 53     ANIMAL HUSBANDRY GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 54     BIOMEDICAL RESEARCH GLOBAL MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 55     BIOMEDICAL RESEARCH GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 56     DNA SEQUENCING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 57     GENOTYPING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 58     BIOMARKER DISCOVERY GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 59     GENE EXPRESSION AND GENETIC MAPPING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 60     DNA CLONING GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 61     OTHER BIOMEDICAL RESEARCH APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 62     OTHER PCR INDUSTRY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 63     OTHER PCR APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 64     PCR GLOBAL MARKET REVENUE, BY END-USERS, (2018-2025) ($MN)
      • TABLE 65     HOSPITALS AND LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 66     PHARMACEUTICALS, CRO'S AND BIOTECH GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 67     ACADEMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 68     OTHER PCR END USERS MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 69     PCR GLOBAL MARKET REVENUE, BY REGION, (2018-2025) ($MN)
      • TABLE 70     NORTH AMERICA PCR MARKET REVENUE, BY TECHNIQUES, (2018-2025) ($MN)
      • TABLE 71     NORTH AMERICA PCR MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 72     NORTH AMERICA INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 73     NORTH AMERICA REAGENTS & CONSUMABLES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 74     NORTH AMERICA PCR MARKET REVENUE, BY APPLICATION, (2018-2025) ($MN)
      • TABLE 75     NORTH AMERICA CLINICAL DIAGNOSTICS MARKET REVENUE, BY APPLICATION TYPE, (2018-2025) ($MN)
      • TABLE 76     NORTH AMERICA INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 77     NORTH AMERICA NON-INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 78     NORTH AMERICA INDUSTRIAL APPLICATIONS MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 79     NORTH AMERICA APPLIED TESTING MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 80     NORTH AMERICA BIOMEDICAL RESEARCH MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 81     NORTH AMERICA PCR MARKET REVENUE, BY END-USERS, (2018-2025) ($MN)
      • TABLE 82     NORTH AMERICA PCR MARKET REVENUE, BY COUNTRY, (2018-2025) ($MN)
      • TABLE 83     EUROPE PCR MARKET REVENUE, BY TECHNIQUES, (2018-2025) ($MN)
      • TABLE 84     EUROPE PCR MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 85     EUROPE INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 86     EUROPE REAGENTS & CONSUMABLES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 87     EUROPE PCR MARKET REVENUE, BY APPLICATION, (2018-2025) ($MN)
      • TABLE 88     EUROPE CLINICAL DIAGNOSTICS MARKET REVENUE, BY APPLICATION TYPE, (2018-2025) ($MN)
      • TABLE 89     EUROPE INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 90     EUROPE NON-INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 91     EUROPE INDUSTRIAL APPLICATIONS MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 92     EUROPE APPLIED TESTING MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 93     EUROPE BIOMEDICAL RESEARCH MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 94     EUROPE PCR MARKET REVENUE, BY END-USERS, (2018-2025) ($MN)
      • TABLE 95     EUROPE PCR MARKET REVENUE, BY COUNTRY, (2018-2025) ($MN)
      • TABLE 96     APAC PCR MARKET REVENUE, BY TECHNIQUES, (2018-2025) ($MN)
      • TABLE 97     APAC PCR MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 98     APAC INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 99     APAC REAGENTS & CONSUMABLES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 100     APAC PCR MARKET REVENUE, BY APPLICATION, (2018-2025) ($MN)
      • TABLE 101     APAC CLINICAL DIAGNOSTICS MARKET REVENUE, BY APPLICATION TYPE, (2018-2025) ($MN)
      • TABLE 102     APAC INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 103     APAC NON-INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 104     APAC INDUSTRIAL APPLICATIONS MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 105     APAC APPLIED TESTING MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 106     APAC BIOMEDICAL RESEARCH MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 107     APAC PCR MARKET REVENUE, BY END-USERS, (2018-2025) ($MN)
      • TABLE 108     APAC PCR MARKET REVENUE, BY COUNTRY, (2018-2025) ($MN)
      • TABLE 109     ROW PCR MARKET REVENUE, BY TECHNIQUES, (2018-2025) ($MN)
      • TABLE 110     ROW PCR MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 111     ROW INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE, (2018-2025) ($MN)
      • TABLE 112     ROW REAGENTS & CONSUMABLES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 113     ROW PCR MARKET REVENUE, BY APPLICATION, (2018-2025) ($MN)
      • TABLE 114     ROW CLINICAL DIAGNOSTICS MARKET REVENUE, BY APPLICATION TYPE, (2018-2025) ($MN)
      • TABLE 115     ROW INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 116     ROW NON-INFECTIOUS DISEASES MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 117     ROW INDUSTRIAL APPLICATIONS MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 118     ROW APPLIED TESTING MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 119     ROW BIOMEDICAL RESEARCH MARKET REVENUE, BY TYPE, (2018-2025) ($MN)
      • TABLE 120     ROW PCR MARKET REVENUE, BY END-USERS, (2018-2025) ($MN)
      • TABLE 121     ROW PCR MARKET REVENUE, BY COUNTRY, (2018-2025) ($MN)
      • TABLE 122     APPROVALS (2016-2019)
      • TABLE 123     NEW PRODUCT LAUNCH (2016-2019)
      • TABLE 124     ACQUISITION, AGREEMENT AND PARTNERSHIP (2016-2019)
      • TABLE 125     OTHERS (2016-2019)
      • TABLE 126     ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 127     ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 128     ABBOTT LABORATORIES, INC.: DIAGNOSTICS REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 129     ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 130     AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 131     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 132     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 133     BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 134     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 135     BECTON DICKINSON AND COMPANY: LIFE SCIENCES REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 136     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 137     BIOMERIEUX: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 138     BIOMEURIEX: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 139     BIOMEURIEX: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 140     BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 141     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 142     BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 143     F.HOFFMANN-LA RACHE: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 144     F.HOFFMANN-LA ROCHE: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 145     F.HOFFMANN-LA ROCHE: DIAGNOSTICS REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 146     F.HOFFMAN LA ROCHE: DIAGNOSTICS REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 147     GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 148     GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 149     GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 150     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 151     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 152     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 153     QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 154     QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 155     QIAGEN N.V.: MOLECULAR DIAGNOSTICS REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 156     QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 157     TAKARA BIO, INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 158     TAKARA BIO, INC.: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
      • TABLE 159     TAKARA BIO INC.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 160     THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 161     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 162     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PCR GLOBAL MARKET REVENUE, BY REGION (2018-2025) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PCR GLOBAL MARKET
      • FIGURE 3     PCR GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PCR GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PCR GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PCR GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PCR GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     PCR GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     PCR GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 11     PCR MARKET: PATENT FILING BY MAJOR PLAYERS(2014-2018)
      • FIGURE 12     PCR GLOBAL MARKET SHARE, BY TECHNIQUES (2019 V/S 2025) (%)
      • FIGURE 13     STANDARD PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 14     REAL TIME PCR/QPCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 15     REVERSE TRANSCRIPTASE PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 16     DIGITAL PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 17     ASSEMBLY PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 18     MULTIPLEX PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 19     HOT START PCR GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 20     OTHER PCR TECHNIQUES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 21     PCR GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2025) (%)
      • FIGURE 22     INSTRUMENTS GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2025) (%)
      • FIGURE 23     INSTRUMENTS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 24     REAGENTS AND CONSUMABLES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2025) (%)
      • FIGURE 25     REAGENTS AND CONSUMABLES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 26     ENZYMES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 27     SOFTWARE & SERVICES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 28     PCR GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2025) (%)
      • FIGURE 29     CLINICAL DIAGNOSTICS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2019 V/S 2025) (%)
      • FIGURE 30     CLINICAL DIAGNOSTICS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 31     INFECTIOUS DISEASES GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2025) (%)
      • FIGURE 32     INFECTIOUS DISEASES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 33     NON-INFECTIOUS DISEASES GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2025) (%)
      • FIGURE 34     NON-INFECTIOUS DISEASES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 35     INDUSTRIAL APPLICATIONS GLOBAL MARKET SHARE, BY TYPE, (2019 V/S 2025) (%)
      • FIGURE 36     INDUSTRIAL APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 37     AGRICULTURE GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 38     ENVIRONMENT GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 39     APPLIED TESTING GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2025) (%)
      • FIGURE 40     APPLIED TESTING GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 41     ANIMAL HUSBANDRY GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 42     BIOMEDICAL RESEARCH GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2025) (%)
      • FIGURE 43     BIOMEDICAL RESEARCH GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 44     OTHER PCR INDUSTRY APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 45     OTHER PCR APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 46     PCR GLOBAL MARKET SHARE, BY END-USERS (2019 V/S 2025) (%)
      • FIGURE 47     HOSPITALS AND LABORATORIES GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 48     PHARMACEUTICALS, CRO’S AND BIOTECH GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 49     ACADEMICS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 50     OTHER PCR END-USERS GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2025) (%)
      • FIGURE 51     PCR GLOBAL MARKET REVENUE, BY REGION (2018-2025) ($MN), CAGR (%)
      • FIGURE 52     PCR GLOBAL MARKET SHARE, BY GEOGRAPHY (2019) (%)
      • FIGURE 53     NORTH AMERICA PCR MARKET SHARE, BY TECHNIQUES, PRODUCTS AND PRODUCTS MARKET SHARE BY TYPE (2019 V/S 2025) (%)
      • FIGURE 54     NORTH AMERICA PCR MARKET SHARE, BY APPLICATION (2019 V/S 2025) (%)
      • FIGURE 55     NORTH AMERICA PCR MARKET SHARE, BY CLINICAL DIAGNOSTICS TYPE (2019 V/S 2025) (%)
      • FIGURE 56     NORTH AMERICA PCR MARKET SHARE, BY INDUSTRIAL APPLICATIONS TYPE (2019 V/S 2025) (%)
      • FIGURE 57     NORTH AMERICA PCR MARKET SHARE, BY END-USERS (2019 V/S 2025) (%)
      • FIGURE 58     NORTH AMERICA PCR MARKET SHARE, BY COUNTRY (2019 V/S 2025) (%)
      • FIGURE 59     U.S. PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 60     U.S. PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 61     REST OF NORTH AMERICA PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 62     REST OF NORTH AMERICA PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 63     EUROPE PCR MARKET SHARE, BY TECHNIQUES, PRODUCTS AND PRODUCTS MARKET SHARE BY TYPE (2019 V/S 2025) (%)
      • FIGURE 64     EUROPE PCR MARKET SHARE, BY APPLICATION (2019 V/S 2025) (%)
      • FIGURE 65     EUROPE PCR MARKET SHARE, BY CLINICAL DIAGNOSTICS TYPE (2019 V/S 2025) (%)
      • FIGURE 66     EUROPE PCR MARKET SHARE, BY INDUSTRIAL APPLICATIONS TYPE (2019 V/S 2025) (%)
      • FIGURE 67     EUROPE PCR MARKET SHARE, BY END-USERS (2019 V/S 2025) (%)
      • FIGURE 68     EUROPE PCR MARKET SHARE, BY COUNTRY (2019 V/S 2025) (%)
      • FIGURE 69     GERMANY PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 70     GERMANY PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 71     U.K. PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 72     U.K. PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 73     FRANCE PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 74     FRANCE PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 75     REST OF EUROPE PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 76     REST OF EUROPE PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 77     APAC PCR MARKET SHARE, BY TECHNIQUES, PRODUCTS AND PRODUCTS MARKET SHARE BY TYPE (2019 V/S 2025) (%)
      • FIGURE 78     APAC PCR MARKET SHARE, BY APPLICATION (2019 V/S 2025) (%)
      • FIGURE 79     APAC PCR MARKET SHARE, BY CLINICAL DIAGNOSTICS TYPE (2019 V/S 2025) (%)
      • FIGURE 80     APAC PCR MARKET SHARE, BY INDUSTRIAL APPLICATIONS TYPE (2019 V/S 2025) (%)
      • FIGURE 81     APAC PCR MARKET SHARE, BY END-USERS (2019 V/S 2025) (%)
      • FIGURE 82     APAC PCR MARKET SHARE, BY COUNTRY (2019 V/S 2025) (%)
      • FIGURE 83     CHINA PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 84     CHINA PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 85     JAPAN PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 86     JAPAN PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 87     INDIA PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 88     INDIA PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 89     REST OF APAC PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 90     REST OF APAC PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 91     ROW PCR MARKET SHARE, BY TECHNIQUES, PRODUCTS AND PRODUCTS MARKET SHARE BY TYPE (2019 V/S 2025) (%)
      • FIGURE 92     ROW PCR MARKET SHARE, BY APPLICATION (2019 V/S 2025) (%)
      • FIGURE 93     ROW PCR MARKET SHARE, BY CLINICAL DIAGNOSTICS TYPE (2019 V/S 2025) (%)
      • FIGURE 94     ROW PCR MARKET SHARE, BY INDUSTRIAL APPLICATIONS TYPE (2019 V/S 2025) (%)
      • FIGURE 95     ROW PCR MARKET SHARE, BY END-USERS (2019 V/S 2025) (%)
      • FIGURE 96     ROW PCR MARKET SHARE, BY COUNTRY (2019 V/S 2025) (%)
      • FIGURE 97     BRAZIL PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 98     BRAZIL PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 99     REST OF LATAM PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 100     REST OF LATAM PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 101     MIDDLE EAST & OTHERS PCR MARKET REVENUE, BY TECHNIQUES (2019 V/S 2025) ($MN)
      • FIGURE 102     MIDDLE EAST & OTHERS PCR MARKET REVENUE, BY PRODUCT, APPLICATION AND END-USER (2019 V/S 2025) ($MN)
      • FIGURE 103     KEY GROWTH STRATEGIES, (2016-2019)
      • FIGURE 104     SWOT: ABBOTT LABORATORIES, INC.
      • FIGURE 105     SWOT: AGILENT TECHNOLOGIES
      • FIGURE 106     SWOT: BECTON DICKINSON AND COMPANY
      • FIGURE 107     SWOT: BIOMERIEUX
      • FIGURE 108     SWOT: BIO-RAD LABORATORIES
      • FIGURE 109     SWOT: ROCHE DIAGNOSTICS
      • FIGURE 110     SWOT: GE HEALTHCARE
      • FIGURE 111     SWOT: MERCK KGAA
      • FIGURE 112     SWOT: PROMEGA CORPORATION
      • FIGURE 113     SWOT: QIAGEN N.V.
      • FIGURE 114     SWOT: TAKARA BIO INC
      • FIGURE 115     SWOT: THERMO FISHER SCIENTIFIC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     Abbott Laboratories, Inc.
      • 2     ADS Biotec, Inc.
      • 3     Agena Bioscience, Inc.
      • 4     Agilent Technologies
      • 5     Ahram Biosystems, Inc.
      • 6     AlphaHelix Molecular Diagnostics AB (publ)
      • 7     ALS Limited
      • 8     Altheadx, Inc.
      • 9     Altona Diagnostics GmbH
      • 10     Amoy Diagnostics Co., Ltd.
      • 11     Ampliqon A/S
      • 12     Analytik Jena AG
      • 13     Andiatec Gmbh
      • 14     Avance Biosciences
      • 15     Beckman Coulter, Inc.
      • 16     Becton Dickinson and Company
      • 17     BGI Group
      • 18     Bibby Scientific Limited
      • 19     Bio Basic Inc.
      • 20     Bioaspect Inc.
      • 21     BioAzure Technologies Pvt. Ltd.
      • 22     Biokit S.A
      • 23     Biolabmix.ru.
      • 24     Biomerieux SA
      • 25     Bioneer Corporation
      • 26     BIOplastics BV
      • 27     Bio-Rad Laboratories, Inc.
      • 28     Biorbyt Ltd.
      • 29     Bioron GmbH
      • 30     Biosmart Gmbh
      • 31     Biosynex S.A.
      • 32     Biotecon Diagnostics GmbH
      • 33     Biotools, Inc.
      • 34     BJS Biotechnologies Ltd.
      • 35     Blackhills Diagostics Resources
      • 36     Brooks Life Sciences.(4titude Ltd)
      • 37     BTS Group AB
      • 38     CareDx, Inc.
      • 39     Carpegen GmbH
      • 40     Celtic Molecular Diagnostics
      • 41     Cleaver Scientific Ltd.
      • 42     CLONIT Srl.
      • 43     Corning, Inc.
      • 44     Cusabio Life Science (Prolab Marketing Pvt. Ltd.)
      • 45     Cytocell Ltd.
      • 46     Da An Gene Co.
      • 47     Devyser AB
      • 48     DiagCor Bioscience Incorporation Limited
      • 49     DiaSorin S.p.A.
      • 50     Diatherix Eurofins, LLC
      • 51     DMS Inc.
      • 52     Dna Polymerase Technology
      • 53     DNAVision SA
      • 54     Doctors Laboratory (TDL)
      • 55     DSS Imagetech
      • 56     EAG labs
      • 57     EMLab P&K, LLC
      • 58     Eppendorf, AG
      • 59     Evans Materials Technology (Shanghai) Company Limited
      • 60     F.Hoffmann-La Roche AG (Roche diagnostics)
      • 61     Fera Science Limited
      • 62     Fisher Biotech
      • 63     Fluidigm corporation
      • 64     Formulatrix, Inc.
      • 65     Fosun International Limited
      • 66     GeneFirst Ltd.
      • 67     Geneflux Bioscience Sdn Bhd
      • 68     Genekam Biotechnology AG
      • 69     Genemed Biotechnologies, Inc.
      • 70     GeneOmbio Technologies Pvt. Ltd.
      • 71     Geneon GmbH
      • 72     GeneProof A.S.
      • 73     General Biologicals Corporation
      • 74     General Electric Company (GE Healthcare)
      • 75     Genesystem.co.kr
      • 76     Genetic Analysis Strategies S.L
      • 77     Genomictree Inc.
      • 78     GlaxoSmithKline PLC
      • 79     GNA Biosolutions GmbH
      • 80     Gosselin
      • 81     Heal Force Bio-meditech Holdings Limited
      • 82     Hokkaido System Science Co.
      • 83     Horiba, Ltd.
      • 84     Hudson Robotics, Inc
      • 85     Hy Laboratories Ltd. (hylabs)
      • 86     Illumina, Inc (Epicentre)
      • 87     Immuno Concepts, Inc.
      • 88     Imperial Life Sciences (P) Limited
      • 89     Inqaba Biotechnical Industries (Pty) Ltd.
      • 90     INTAS Science Imaging Instruments GmbH
      • 91     Invivoscribe, Inc
      • 92     Jena Bioscience GmbH
      • 93     Kaneka Corporation (Eurogentec)
      • 94     Kogene.co.kr
      • 95     KOMA Biotech, Inc.
      • 96     KYRATEC
      • 97     LabGear Australia
      • 98     LABGENE Scientific SA
      • 99     LGC Limited
      • 100     Lumex Instruments
      • 101     Maxima Biotech, Inc.
      • 102     MBR, Inc. ( Molecular Biology Resources)
      • 103     Merck KgaA
      • 104     Minerva Biolabs GmbH
      • 105     Molecular diagnostic service
      • 106     Molzym GmbH & Co. KG
      • 107     Neogen Corporation
      • 108     Nimagen B.V.
      • 109     Nordic BioSite AB
      • 110     Norgen Biotech Corp.
      • 111     Nuclea Biotechnologies, Inc.
      • 112     Operon S.A.
      • 113     Oyc Eu B.V.
      • 114     Panagene Inc.
      • 115     Pathofinder B.V.
      • 116     PCR Biosystems Ltd
      • 117     PCR Max Ltd.
      • 118     PentaBase ApS
      • 119     Pharmigene, Inc.
      • 120     Precipio, Inc.
      • 121     Premier Biosoft International
      • 122     Promega Corporation
      • 123     Property Casualty Resource Services, Inc.
      • 124     Proteogenix
      • 125     Qiagen N.V.
      • 126     Reagecon Diagnostics Ltd.
      • 127     REPROCELL USA, Inc.
      • 128     Romer Labs UK Ltd.
      • 129     Rose Gentec Ltd.
      • 130     Sarstedt AG & Co. KG
      • 131     Scientific Specialties Inc.
      • 132     Seegene, Inc.
      • 133     Sekisui Diagnostics, LLC
      • 134     SGS North America, Inc.
      • 135     Siemens Healthcare GmbH
      • 136     SolGent co, LTD
      • 137     SOLVIAS AG
      • 138     Sorenson Bioscience, Inc. (Axygen, Inc.)
      • 139     Sotera Health, LLC
      • 140     Source BioScience
      • 141     Surrey Diagnostics Limited
      • 142     Syntezza Bioscience Ltd.
      • 143     Takara Bio Inc.
      • 144     TATAA Biocenter
      • 145     TCS Biosciences Ltd.
      • 146     Tetracore, Inc.
      • 147     Texas Biogene, Inc.
      • 148     Thermo Fisher Scientific, Inc.
      • 149     Tib Molbiol GmbH
      • 150     TrimGen Corporation
      • 151     U.S. EcoGen, LLC.
      • 152     VacuTec Meßtechnik GmbH
      • 153     Vircell S.L.
      • 154     Zhengzhou Nanbei Instrument Equipment Co. Ltd.
      • 155     Zymo Research Corporation